Pharmafile Logo
Pharmafocus logo
Advanced Search
essure

Bayer contraceptive implant public backlash brings results

April 12, 2018
Medical Communications, Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical

Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with …

News
kenneth-newman_credit_verona_pharma

Verona Pharma loses Chief Medical Officer

April 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, verona pharma

Verona Pharma has revealed that it is to part ways with its Chief Medical Officer at the end of the …

Appointment
abbvieuse_054_low

AbbVie’s rheumatoid arthritis drug bests even its own blockbuster Humira at Phase 3

April 11, 2018
Research and Development AbbVie, Humira, pharma, rheumatoid arthritis, upadacitinib

AbbVie posted a strong showing this week from its JAK1 inhibitor upadacitinib, indicating that the drug outperformed even its own …

News
csm_packshot_kineret_814229b3fc

Sobi receives expanded EU approval for Kineret

April 11, 2018
Research and Development, Sales and Marketing Kineret, anti-inflammatory, biotech, drugs, pharma, pharmaceutical, sobi

Joining its current indication as a treatment for rheumatoid arthritis and cryopyrin-associated periodic syndromes, Sobi’s Kineret has been given approval …

News
pfizer_hq_dark

Pfizer shuts down kidney cancer drug trial due to “futility”

April 11, 2018
Research and Development Cancer, Kidney cancer, Pfizer, inlyta, pharma

Pfizer has revealed that it has shut down a trial of its vascular endothelial growth factor (VEGF) inhibitor Inlyta (axitinib) …

News

Alexion $855m portfolio boost after Wilson Therapeutics buyout

April 11, 2018
Research and Development, Sales and Marketing Alexion, Wilson's Therapeutics, Wilson's disease, biotech, drugs, pharma, pharmaceutical

Alexion Pharmaceuticals is badly in need of alternative revenue streams to Soliris, its mega-blockbuster that could start to face competition …

News
mylan

Mylan looks to hit Teva where it hurts, eyeing slow-release MS treatment

April 11, 2018
Research and Development, Sales and Marketing Copaxone, Mapi Pharma, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Mylan has taken several steps recently that seem intended to hit sales of its big rivals on their key products, …

News
theresa_may_-_credit_arno_mikkor

May announces £75m prostate cancer boost

April 10, 2018
Manufacturing and Production, Medical Communications Prostate Cancer UK, UK, biotech, drugs, pharma, pharmaceutical, prostate cancer

Prostate cancer has begun to receive more publicity in recent years in the UK, but not for the right reasons. …

News
msd

Keytruda scores big as a first-line monotherapy in NSCLC patients with any level of PD-L1 expression

April 10, 2018
Manufacturing and Production, Research and Development Cancer, MSD, NSCLC, keytruda, lung cancer, pharma

Closely following the news that Keytruda (pembrolizumab) had failed in the treatment of unresectable or metastatic melanoma as a combination …

News
woman-1246587_960_720

Media reports over Parkinson’s drug risk hit Acadia hard

April 10, 2018
Manufacturing and Production, Medical Communications Acadia Pharmaceutical, biotech, drugs, pharma, pharmaceutical

Shortly after the Institute for Safe Medication Practices released a report revealing the number of deaths of patients in those …

News
brain-1787622_640

Antiepileptic drug use linked to increased risk of Alzheimer’s and dementia

April 10, 2018
Manufacturing and Production, Research and Development Alzheimer's disease, dementia, epilepsy, pharma

A new study conducted at the University of Eastern Finland and the German Center for Neurodegenerative Diseases (DZNE) has revealed …

News
iannone

Immunomedics’ whirlwind in the C-suite continues

April 10, 2018
Manufacturing and Production, Medical Communications AstraZeneca, Immunomedics, Seattle Genetics, biotech, drugs, pharma, pharmaceutical

Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …

News
fighting_cancer

Looking to the future of oncology

April 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, oncology, pharma

The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …

Feature
800px-prostate_cancer_1

Almost 40% of UK prostate cancer cases are diagnosed late, according to report

April 9, 2018
Medical Communications, Research and Development, Sales and Marketing Cancer, UK, pharma, prostate cancer

A report conducted by charity Orchid has revealed a “worrying trend” in the treatment of prostate cancer, indicating that as …

News
instagram-3198093_960_720

Facebook takes action against drug peddlers on Instagram

April 9, 2018
Medical Communications, Sales and Marketing Facebook, biotech, drugs, fentanyl, instagram, opioid, opioid epidemic, pharma, pharmaceutical

Facebook can’t catch a break at the moment, after being widely criticised for its practices over the security of users’ …

News
roche_glass_building

Tecentriq third time lucky after NICE nod in lung cancer

April 9, 2018
Sales and Marketing NICE, Roche, biotech, drugs, lung cancer, pharma, pharmaceutical, tecentriq

After having been knocked by twice by NICE, Roche has finally received a recommendation for Tecentriq’s second-line use in non-small …

News
merckincweb

Keytruda combo fails at Phase 3 in metastatic melanoma

April 9, 2018
Research and Development, Sales and Marketing Incyte, MSD, keytruda, pharma, trial failure

Shares in biopharma firm Incyte were sent reeling by as much as 20% when the company announced that the results …

News

Novartis CEO makes mark with $8.7bn AveXis acquisition

April 9, 2018
Sales and Marketing AveXis, Novartis, biotech, drugs, gene therapy, pharma, pharmaceutical

Vas Narasimhan’s first few moves as CEO of Novartis indicate that he is not afraid to take bold risks in …

News
humira_abbott__4

Samsung Bioepis and Biogen secure licensing deal with Abbvie for Humira biosimilar

April 6, 2018
Medical Communications, Sales and Marketing AbbVie, Biogen, Humira, Imraldi, Samsung Bioepis, biosimilar, pharma

Partners Biogen and Samsung Bioepis have secured the future of their Humira (adalimumab) biosimilar after penning a deal with Abbvie …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

April 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Boehringer Ingelheim, Kite, Nordic Nanovector, Pfizer, Roche, Sanofi, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Some of the biggest news this week concerns companies that are looking to move on parts of their business, but …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026